13 completed. 13 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 13 |
Follow Menactra®: new trials by email Literature Review of Menactra® trials Research Report on Menactra®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1528 | 2023-03-27 | 2026-01-21 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine), Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningococcal Immunisation (Healthy Volunteers) | Phase 3 | Completed | Sanofi | 360 | 2020-05-22 | 2025-09-15 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine, Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine, Meningococcal polysaccharide (serogroups A, C, Y and W-135) vaccine - Meningococcal Immunization, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1328 | 2019-12-30 | 2025-02-03 |
| Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 3344 | 2016-07-15 | 2022-04-05 |
| Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 810 | 2016-04-15 | 2022-04-05 |
| Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation Meningococcal Diphtheria Toxoid Vaccine - Meningitis, Meningococcal Infection | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 300 | 2013-06-25 | 2022-04-19 |
| Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed - Meningitis, Meningococcal Disease | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 300 | 2012-07-01 | 2013-12-03 |
| Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®, Meningococcal Group C Conjugate vaccine: MenC - Meningitis, Meningococcal Infection | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 123 | 2011-05-01 | 2016-08-19 |
| A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®) - Meningococcal Infection, Meningitis | Phase 3 | Completed | Sanofi | 300 | 2010-06-01 | 2012-02-06 |
| Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate, Measles-mumps-rubella-varicella vaccine, Routine paediatric vaccine - Pneumococcal conjugate (PCV) - Meningococcal Meningitis, Measles | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1378 | 2007-05-01 | 2016-05-16 |
| Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine, Mencevax®: Group A, C, W135 and Y polysaccharide meningococcal vaccine - Neisseria Meningitidis, Meningococcal Infections | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 450 | 2007-02-01 | 2015-07-14 |
| Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers Meningococcal Polysaccharide Diphtheria Conjugate Vaccine, Measles, Mumps, Rubella and Varicella - Meningococcal Meningitis, Measles | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1664 | 2006-12-01 | 2016-04-14 |
| A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Meningococcal Polysaccharide Diphtheria Toxoid Conjugate - Meningococcal Meningitis, Measles | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1128 | 2006-09-01 | 2016-04-14 |
Meningococcal Infections (7) · Meningitis (6) · Meningitis, Meningococcal (5) · Chickenpox (3) · Haemophilus Infections (3) · Measles (3) · Mumps (3) · Rubella (3) · Meningitis, Bacterial (1)
Sanofi Pasteur, a Sanofi Company (11) · Sanofi (2)
United States (5) · India (4) · Puerto Rico (2) · South Africa (2) · Canada (1) · Chile (1) · Japan (1) · Russia (1) · Saudi Arabia (1) · South Korea (1)
2018 (1)